Bayer AG annual gross profit
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Gross Profit Growth & History (BAYN)
Bayer AG's gross profit was €26.78B for fiscal 2025.
View full Bayer AG company overviewBayer AG annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €26.78B | €1.44B | +5.69% |
| 2024 | 2024-12-31 | €25.34B | −€2.55B | −9.15% |
| 2023 | 2023-12-31 | €27.89B | −€2.98B | −9.65% |
| 2022 | 2022-12-31 | €30.87B | €3.60B | +13.21% |
| 2021 | 2021-12-31 | €27.27B | €5.00B | +22.47% |
| 2020 | 2020-12-31 | €22.26B | −€3.82B | −14.63% |
| 2019 | 2019-12-31 | €26.08B | €3.50B | +15.51% |
| 2018 | 2018-12-31 | €22.58B | −€1.06B | −4.47% |
| 2017 | 2017-12-31 | €23.63B | −€2.84B | −10.73% |
| 2016 | 2016-12-31 | €26.47B | €1.31B | +5.20% |
| 2015 | 2015-12-31 | €25.17B | €3.19B | +14.53% |
| 2014 | 2014-12-31 | €21.97B | €886.0M | +4.20% |
| 2013 | 2013-12-31 | €21.09B | −€698.0M | −3.20% |
| 2012 | 2012-12-31 | €21.79B | €2.36B | +12.15% |
| 2011 | 2011-12-31 | €19.43B | −€528.0M | −2.65% |
| 2010 | 2010-12-31 | €19.95B | — | — |
Bayer AG gross profit trends
Over the last five fiscal years, Bayer AG's gross profit increased from €22.26B to €26.78B, a change of €4.52B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
reported and calculated gross profit
TickerStat uses gross profit reported in company official filings when available. Otherwise, it calculates gross profit as reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
